Prevalence and Genotype Distribution of Human Papillomavirus Among Healthy Females in Beijing, China, 2016–2019

References

• Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394–424. doi:10.3322/caac.2149230207593
   PubMed Web of Science ®Google Scholar
• Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Erratum: global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2020;70(4):313. doi:10.3322/caac.21609
   Web of Science ®Google Scholar
• Arbyn M, Weiderpass E, Bruni L, et al. Estimates of incidence and mortality of cervical cancer in 2018: a worldwide analysis. Lancet Glob Health. 2020;8(2):e191–e203. doi:10.1016/S2214-109X(19)30482-631812369
   PubMed Web of Science ®Google Scholar
• Walboomers JM, Jacobs MV, Manos MM, et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol. 1999;189(1):12–19. doi:10.1002/(SICI)1096-9896(199909)189:1<12::AID-PATH431>3.0.CO;2-F10451482
   PubMed Web of Science ®Google Scholar
• Wang R, Pan W, Jin L, et al. Human papillomavirus vaccine against cervical cancer: opportunity and challenge. Cancer Lett. 2020;471:88–102. doi:10.1016/j.canlet.2019.11.03931812696
   PubMed Web of Science ®Google Scholar
• Lorincz AT, Reid R, Jenson BA, et al. Human papillomavirus infection of the cervix: relative risk associations of 15 common anogenital types. Obstet Gynecol. 1992;79(3):328–337. doi:10.1097/00006250-199203000-000021310805
   PubMed Web of Science ®Google Scholar
• American College of Obstetricians and Gynecologists. Practice bulletin no. 168: cervical cancer screening and prevention. Obstet Gynecol. 2016;128(4):e111–e130. doi:10.1097/AOG.000000000000170827661651
   PubMed Web of Science ®Google Scholar
• Wardak S. Human Papillomavirus (HPV) and cervical cancer. Med Dosw Mikrobiol. 2016;68(1):73–84.28146625
   PubMedGoogle Scholar
• Rerucha CM, Caro RJ, Wheeler VL. Cervical cancer screening. Am Fam Physician. 2018;97(7):441–448.29671553
   PubMed Web of Science ®Google Scholar
• Bedell SL, Goldstein LS, Goldstein AR, et al. Cervical cancer screening: past, present, and future. Sex Med Rev. 2020;8(1):28–37. doi:10.1016/j.sxmr.2019.09.00531791846
   PubMed Web of Science ®Google Scholar
• Markowitz LE, Hariri S, Lin C, et al. Reduction in human papillomavirus (HPV) prevalence among young women following HPV vaccine introduction in the United States, National Health and Nutrition Examination Surveys, 2003–2010. J Infect Dis. 2013;208(3):385–393. doi:10.1093/infdis/jit19223785124
   PubMed Web of Science ®Google Scholar
• Markowitz LE, Liu G, Hariri S, et al. Prevalence of HPV after introduction of the vaccination program in the United States. Pediatrics. 2016;137(3):e20151968. doi:10.1542/peds.2015-196826908697
   PubMed Web of Science ®Google Scholar
• Barton MK. Declines in human papillomavirus infection observed in the vaccine era. CA Cancer J Clin. 2013;63(6):369–370. doi:10.3322/caac.2120024122694
   PubMed Web of Science ®Google Scholar
• de Sanjose S, Diaz M, Castellsagué X, et al. Worldwide prevalence and genotype distribution of cervical human papillomavirus DNA in women with normal cytology: a meta-analysis. Lancet Infect Dis. 2007;7(7):453–459. doi:10.1016/S1473-3099(07)70158-517597569
   PubMed Web of Science ®Google Scholar
• Baloch Z, Yasmeen N, Li Y, et al. Prevalence and risk factors for human papillomavirus infection among Chinese ethnic women in southern of Yunnan, China. Braz J Infect Dis. 2017;21(3):325–332. doi:10.1016/j.bjid.2017.01.00928284657
   PubMed Web of Science ®Google Scholar
• Ogembo RK, Gona PN, Seymour AJ, et al. Prevalence of human papillomavirus genotypes among African women with normal cervical cytology and neoplasia: a systematic review and meta-analysis. PLoS One. 2015;10(4):e0122488. doi:10.1371/journal.pone.012248825875167
   PubMed Web of Science ®Google Scholar
• Zhao XL, Hu S-Y, Zhang Q, et al. High-risk human papillomavirus genotype distribution and attribution to cervical cancer and precancerous lesions in a rural Chinese population. J Gynecol Oncol. 2017;28(4):e30. doi:10.3802/jgo.2017.28.e3028541628
   PubMed Web of Science ®Google Scholar
• Melnikow J, Henderson JT, Burda BU, Senger CA, Durbin S, Soulsby MA. Screening for cervical cancer with high-risk human papillomavirus testing: a systematic evidence review for the U.S. Preventive Services Task Force. JAMA. 2018;320(7):687–705. doi:10.1001/jama.2018.1040030140883
   PubMed Web of Science ®Google Scholar
• Zhang C, Zhang C, Huang J, et al. Prevalence and genotype distribution of human papillomavirus among females in the suburb of Shanghai, China. J Med Virol. 2018;90(1):157–164. doi:10.1002/jmv.2489928700089
   PubMed Web of Science ®Google Scholar
• Liu J, Ma S, Qin C, et al. Prevalence and genotype distribution of human papillomavirus in Zhengzhou, China, in 2016. Arch Virol. 2020;165(3):731–736. doi:10.1007/s00705-019-04515-331907615
   PubMed Web of Science ®Google Scholar
• Xiang F, Guan Q, Liu X, et al. Distribution characteristics of different human papillomavirus genotypes in women in Wuhan, China. J Clin Lab Anal. 2018;32(8):e22581. doi:10.1002/jcla.2258129862560
   PubMed Web of Science ®Google Scholar
• Wang J, Tang D, Wang K, et al. HPV genotype prevalence and distribution during 2009–2018 in Xinjiang, China: baseline surveys prior to mass HPV vaccination. BMC Womens Health. 2019;19(1):90. doi:10.1186/s12905-019-0785-331286939
   PubMed Web of Science ®Google Scholar
• Zhong TY, Zhou J-C, Hu R, et al. Prevalence of human papillomavirus infection among 71,435 women in Jiangxi Province, China. J Infect Public Health. 2017;10(6):783–788. doi:10.1016/j.jiph.2017.01.01128214188
   PubMed Web of Science ®Google Scholar
• Li B, Wang H, Yang D, et al. Prevalence and distribution of cervical human papillomavirus genotypes in women with cytological results from Sichuan province, China. J Med Virol. 2019;91(1):139–145. doi:10.1002/jmv.2525529981172
   PubMed Web of Science ®Google Scholar
• Li Z, Liu F, Cheng S, et al. Prevalence of HPV infection among 28,457 Chinese women in Yunnan Province, southwest China. Sci Rep. 2016;6:21039. doi:10.1038/srep2103926868772
   PubMed Web of Science ®Google Scholar
• Chen X, Xu H, Xu W, et al. Prevalence and genotype distribution of human papillomavirus in 961,029 screening tests in southeastern China (Zhejiang Province) between 2011 and 2015. Sci Rep. 2017;7(1):14813. doi:10.1038/s41598-017-13299-y29093458
   PubMed Web of Science ®Google Scholar
• Zhao P, Liu S, Zhong Z, et al. Prevalence and genotype distribution of human papillomavirus infection among women in northeastern Guangdong Province of China. BMC Infect Dis. 2018;18(1):204. doi:10.1186/s12879-018-3105-x29724192
   PubMed Web of Science ®Google Scholar
• Zhang C, Cheng W, Liu Q, et al. Distribution of human papillomavirus infection: a population-based study of cervical samples from Jiangsu Province. Virol J. 2019;16(1):67. doi:10.1186/s12985-019-1175-z31109361
   PubMed Web of Science ®Google Scholar
• Cao D, Zhang S, Zhang Q, et al. Prevalence of high-risk human papillomavirus infection among women in Shaanxi province of China: a hospital-based investigation. J Med Virol. 2017;89(7):1281–1286. doi:10.1002/jmv.2474827935120
   PubMed Web of Science ®Google Scholar
• Jiang L, Tian X, Peng D, et al. HPV prevalence and genotype distribution among women in Shandong Province, China: analysis of 94,489 HPV genotyping results from Shandong’s largest independent pathology laboratory. PLoS One. 2019;14(1):e0210311. doi:10.1371/journal.pone.021031130653566
   PubMed Web of Science ®Google Scholar
• Ma L, Lei J, Ma L, et al. Characteristics of women infected with human papillomavirus in a tertiary hospital in Beijing China, 2014–2018. BMC Infect Dis. 2019;19(1):670. doi:10.1186/s12879-019-4313-831357941
   PubMed Web of Science ®Google Scholar
• Zhu B, Liu Y, Zuo T, et al. The prevalence, trends, and geographical distribution of human papillomavirus infection in China: the pooled analysis of 1.7 million women. Cancer Med. 2019;8(11):5373–5385. doi:10.1002/cam4.201731350872
   PubMed Web of Science ®Google Scholar
• Wang R, Guo X-L, Wisman GBA, et al. Nationwide prevalence of human papillomavirus infection and viral genotype distribution in 37 cities in China. BMC Infect Dis. 2015;15:257. doi:10.1186/s12879-015-0998-526142044
   PubMed Web of Science ®Google Scholar
• Bruni L, Diaz M, Castellsagué X, et al. Cervical human papillomavirus prevalence in 5 continents: meta-analysis of 1 million women with normal cytological findings. J Infect Dis. 2010;202(12):1789–1799. doi:10.1086/65732121067372
   PubMed Web of Science ®Google Scholar
• Nogueira Dias Genta ML, Martins TR, Mendoza Lopez RV, et al. Multiple HPV genotype infection impact on invasive cervical cancer presentation and survival. PLoS One. 2017;12(8):e0182854. doi:10.1371/journal.pone.018285428829791
   PubMed Web of Science ®Google Scholar
• Wang L, Wu B, Li J, et al. Prevalence of human papillomavirus and its genotype among 1336 invasive cervical cancer patients in Hunan province, central south China. J Med Virol. 2015;87(3):516–521. doi:10.1002/jmv.2409425604457
   PubMed Web of Science ®Google Scholar
• Steinau M, Hariri S, Gillison ML, et al. Prevalence of cervical and oral human papillomavirus infections among US women. J Infect Dis. 2014;209(11):1739–1743. doi:10.1093/infdis/jit79924319284
   PubMed Web of Science ®Google Scholar
• Wendland EM, Villa LL, Unger ER, et al. Prevalence of HPV infection among sexually active adolescents and young adults in Brazil: the POP-Brazil Study. Sci Rep. 2020;10(1):4920. doi:10.1038/s41598-020-61582-232188884
   PubMed Web of Science ®Google Scholar
• Farahmand M, Moghoofei M, Dorost A, et al. Prevalence and genotype distribution of genital human papillomavirus infection in female sex workers in the world: a systematic review and meta-analysis. BMC Public Health. 2020;20(1):1455. doi:10.1186/s12889-020-09570-z32977797
   PubMed Web of Science ®Google Scholar
• Winer RL, Hughes JP, Feng Q, et al. Early natural history of incident, type-specific human papillomavirus infections in newly sexually active young women. Cancer Epidemiol Biomarkers Prev. 2011;20(4):699–707. doi:10.1158/1055-9965.EPI-10-110821173170
   PubMed Web of Science ®Google Scholar
• Gonzalez P, Hildesheim A, Rodríguez AC, et al. Behavioral/lifestyle and immunologic factors associated with HPV infection among women older than 45 years. Cancer Epidemiol Biomarkers Prev. 2010;19(12):3044–3054. doi:10.1158/1055-9965.EPI-10-064520952561
   PubMed Web of Science ®Google Scholar
• Rositch AF, Burke AE, Viscidi RP, et al. Contributions of recent and past sexual partnerships on incident human papillomavirus detection: acquisition and reactivation in older women. Cancer Res. 2012;72(23):6183–6190. doi:10.1158/0008-5472.CAN-12-263523019223
   PubMed Web of Science ®Google Scholar
• Yip YC, Ngai KLK, Vong H-T, et al. Prevalence and genotype distribution of cervical human papillomavirus infection in Macao. J Med Virol. 2010;82(10):1724–1729. doi:10.1002/jmv.2182620827770
   PubMed Web of Science ®Google Scholar
• Li K, Li Q, Song L, et al. The distribution and prevalence of human papillomavirus in women in mainland China. Cancer. 2019;125(7):1030–1037. doi:10.1002/cncr.3200330748006
   PubMed Web of Science ®Google Scholar
• Ouh YT, Min K-J, Cho HW, et al. Prevalence of human papillomavirus genotypes and precancerous cervical lesions in a screening population in the Republic of Korea, 2014–2016. J Gynecol Oncol. 2018;29(1):e14. doi:10.3802/jgo.2018.29.e1429185272
   PubMed Web of Science ®Google Scholar
• Li K, Yin R, Wang D, et al. Human papillomavirus subtypes distribution among 2309 cervical cancer patients in West China. Oncotarget. 2017;8(17):28502–28509. doi:10.18632/oncotarget.1609328415708
   PubMedGoogle Scholar